Contact Information: For media inquiries please contact: Bari Trontz Trontz PR 212-293-9051 (office) 917-442-8500 (mobile)
Sichenzia Ross Friedman Ference LLP Represents Rodman & Renshaw in Public Offering of Skystar Bio-Pharmaceutical
| Source: Sichenzia Ross Friedman Ference LLP
NEW YORK, NY--(Marketwire - July 7, 2009) - Sichenzia Ross Friedman Ference LLP, a
leading securities law firm specializing in micro, small and mid-cap public
companies, today announced their successful representation of Rodman &
Renshaw, LLC in an underwritten public offering of Skystar
Bio-Pharmaceutical Co., Ltd. (NASDAQ : SKBI ). The offering consists of
1,400,000 shares of common stock at a price of $12.98 per share and an
over-allotment option of an additional 210,000 shares. The total offering
amount was 20,897,000. The offering closed today, July 7, 2009.
This offering "demonstrates the ability for investment bankers and
investors to uncover inherent value in China-based companies whose market
capitalization has been undervalued in this economic climate," said Gregory
Sichenzia, Principal at Sichenzia Ross Friedman Ference. "This transaction
represents a new financing model for small and mid-cap companies to gain
access to and leverage US capital markets. We believe this innovative model
enables companies with diminished share prices and strong earnings to
recapitalize, list on senior exchanges and ultimately raise capital."
Skystar is a China-based developer and distributor of veterinary healthcare
and medical care products. The Company has four product lines (veterinary
medicines, micro-organisms, vaccines and feed additives), approximately 170
products, and over 40 new products in the developmental stage. Skystar has
formed strategic sales distribution networks covering 29 provinces
throughout the China region.
Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc.
(NASDAQ : RODM ), served as sole book-running manager for the offering.
About Sichenzia Ross Friedman Ference LLP
Sichenzia Ross Friedman Ference LLP (SRFF) has led the nation in
representing public companies in private financing transactions since 2004.
The New York based firm has completed over 250 such transactions totaling
over 1 billion dollars. The Firm has also represented many companies and
underwriters in public offerings of securities. The firm's clients include
private and public corporations, partnerships, broker-dealers,
bank-affiliated broker-dealers, investment advisors, registered personnel,
public and corporate customers and investors, partnerships and other
entities. SRFF also maintains specialized Asian and Israeli corporate
practice groups. For more information visit, www.srff.com.